Glaukos Corp. (GKOS)
177.47
-2.88
(-1.60%)
USD |
NYSE |
Sep 04, 16:00
177.48
+0.01
(+0.01%)
After-Hours: 20:00
Glaukos Research and Development Expense (Quarterly) : 51.30M for June 30, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 51.30M |
| March 31, 2026 | 44.14M |
| December 31, 2025 | 43.65M |
| September 30, 2025 | 38.07M |
| June 30, 2025 | 36.54M |
| March 31, 2025 | 32.35M |
| December 31, 2024 | 36.53M |
| September 30, 2024 | 34.75M |
| June 30, 2024 | 34.43M |
| March 31, 2024 | 30.73M |
| December 31, 2023 | 37.06M |
| September 30, 2023 | 33.30M |
| June 30, 2023 | 33.23M |
| March 31, 2023 | 35.17M |
| December 31, 2022 | 35.81M |
| September 30, 2022 | 28.87M |
| June 30, 2022 | 31.71M |
| March 31, 2022 | 26.88M |
| December 31, 2021 | 26.68M |
| September 30, 2021 | 28.85M |
| June 30, 2021 | 29.26M |
| March 31, 2021 | 21.22M |
| December 31, 2020 | 21.24M |
| September 30, 2020 | 20.30M |
| Date | Value |
|---|---|
| June 30, 2020 | 18.97M |
| March 31, 2020 | 24.87M |
| December 31, 2019 | 20.03M |
| September 30, 2019 | 17.28M |
| June 30, 2019 | 17.07M |
| March 31, 2019 | 13.93M |
| December 31, 2018 | 12.96M |
| September 30, 2018 | 13.20M |
| June 30, 2018 | 12.61M |
| March 31, 2018 | 10.91M |
| December 31, 2017 | 10.52M |
| September 30, 2017 | 9.805M |
| June 30, 2017 | 9.633M |
| March 31, 2017 | 8.942M |
| December 31, 2016 | 7.399M |
| September 30, 2016 | 7.807M |
| June 30, 2016 | 6.955M |
| March 31, 2016 | 7.062M |
| December 31, 2015 | 6.295M |
| September 30, 2015 | 6.173M |
| June 30, 2015 | 7.339M |
| March 31, 2015 | 5.24M |
| March 31, 2014 | 4.383M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Abbott Laboratories | 892.00M |
| Alphatec Holdings, Inc. | 18.17M |
| Artivion, Inc. | 9.055M |
| ICU Medical, Inc. | 22.70M |
| Insulet Corp. | 88.10M |